AK
Anil Kumar Shahi
About Anil Kumar Shahi
Data last updated:
Anil Kumar Shahi is a Director at Biomade Life Care Private Limited (since 2020), Director at Chrysalis Pharma Private Limited (since 2014) and Director at Pharmaplus Remedies Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹6.81 Cr; the largest is Biomade Life Care Private Limited at ₹6.74 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jan 2020 | 2020 | ₹6.74 Cr (FY 2024) | Active | |
| Director | 11 Jun 2014 | 2014 | ₹6.6 Lakh (FY 2022) | Active | |
| Director | 17 Jan 2022 | 2022 | ₹2,266 (FY 2024) | Active | |
| Designated Partner | 18 Sep 2019 | 2019 | Active |
Board colleagues of Anil Kumar Shahi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohamad Asif Izaz Ahmed Chaudhary | 08565345 | Biomade Life Care Private Limited , Biomade Life Sciences Llp | Director |
| Riyaz Uddin Khan | 06846963 | Biomade Life Care Private Limited , Chrysalis Pharma Private Limited and 1 more | Director |
| Srijna Shahi | 08153787 | Pharmaplus Remedies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Shahi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Shahi
Anil Kumar Shahi currently holds 4 directorships: Biomade Life Care Private Limited (Director, since 06 Jan 2020, revenue ₹6.74 Cr (FY 2024)); Chrysalis Pharma Private Limited (Director, since 11 Jun 2014, revenue ₹6.6 Lakh (FY 2022)); Pharmaplus Remedies Private Limited (Director, since 17 Jan 2022, revenue ₹2,266 (FY 2024)); Biomade Life Sciences Llp (Designated Partner, since 18 Sep 2019).
Anil Kumar Shahi was first appointed on 11 Jun 2014 as Director at Chrysalis Pharma Private Limited. The most recent appointment on record is 17 Jan 2022 at Pharmaplus Remedies Private Limited.
The 3 current companies of Anil Kumar Shahi that report revenue have a combined latest revenue of ₹6.81 Cr: Biomade Life Care Private Limited ₹6.74 Cr (FY 2024); Chrysalis Pharma Private Limited ₹6.6 Lakh (FY 2022); Pharmaplus Remedies Private Limited ₹2,266 (FY 2024).
The current boards of Anil Kumar Shahi's companies include Mohamad Asif Izaz Ahmed Chaudhary (Biomade Life Care Private Limited), Riyaz Uddin Khan (Biomade Life Care Private Limited), Srijna Shahi (Pharmaplus Remedies Private Limited).